Evidence map›Paper›PMID 40400002›Full record

ArticleBMC proceedings2025

The silent epidemic of non-adherence - insights from the 2024 a:care congress.

Sheri D Pruitt, Rabia Khan, Nathorn Chaiyakunapruk, Arintaya Phrommintikul, Miguel Angel Díaz Aguilera, Ngiap Chuan Tan, Shoaib Afzal, Andressa da Silva van der Laan, John Weinman

Abstract read
In one paragraph

Article in BMC proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sheri D PruittFormer Director of Behavioral Science Integration, Independent Behavioral Science Consultant, Kaiser Permanente, Ada, OK, USA. sheri@drsheripruitt.com.
Rabia KhanSchool of Population Health, University of New South Wales, New South Wales, Australia.
Nathorn ChaiyakunaprukDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
Arintaya PhrommintikulDivision of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Miguel Angel Díaz AguileraNational Center for Preventive Programs and Disease Control, Ministry of Health, Mexico City, Mexico.
Ngiap Chuan TanSingHealth Polyclinics, Singapore, Singapore.
Shoaib AfzalDepartment of Clinical Biochemistry, Copenhagen University Hospital Herlev and Gentofte, Gentofte, Denmark.
Andressa da Silva van der LaanGlobal Innovation and Development, Abbott Product Operations AG, Allshwil, Switzerland.
John WeinmanInstitute of Pharmaceutical Science, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication non-adherence is a global challenge with profound implications for patient health outcomes, healthcare systems, and society at large. This widespread issue leads to hundreds of thousands of preventable deaths and hospitalizations annually, and billions of dollars in avoidable healthcare costs. No country is immune to this challenge. The a:care Congress 2024, titled "Adherence is a Behavior: Do We Have the Right One?", addressed this critical issue to understand its societal and economic burden and explore the complex human behaviors driving it. The Congress examined the global impact of non-adherence and local realities, providing a health economic perspective on its consequences. Behavioral factors influencing adherence were analyzed, emphasizing the importance of understanding individual patient motivations. The role of technology and artificial intelligence in the physician-patient relationship was discussed, highlighting opportunities and challenges of integrating these tools. The patient's voice was brought to the forefront, underscoring the importance of communication and trust in the care relationship. A final multidisciplinary session explored the role of each stakeholder in improving adherence. This article provides an overview of the different sessions from the congress, focusing on the challenges associated with medication non-adherence and potential solutions. It emphasizes the need for a multidimensional approach involving all healthcare system stakeholders and the importance of prioritizing the development of new strategies to improve overall health outcomes and healthcare system efficiency.

Indexed as

Adherence stakeholdersBehavioral scienceBehavior patient-physician relationshipsCongressDigital health technologiesHealth economicsMedication adherenceNon-adherence

Identifiers

PMID40400002
PMCPMC12096470

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.